487 related articles for article (PubMed ID: 18394720)
1. FAAH and anandamide: is 2-AG really the odd one out?
Di Marzo V; Maccarrone M
Trends Pharmacol Sci; 2008 May; 29(5):229-33. PubMed ID: 18394720
[TBL] [Abstract][Full Text] [Related]
2. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol.
Ho WS; Randall MD
Br J Pharmacol; 2007 Mar; 150(5):641-51. PubMed ID: 17245358
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
Walentiny DM; Vann RE; Wiley JL
Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527
[TBL] [Abstract][Full Text] [Related]
4. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
Moreira FA; Kaiser N; Monory K; Lutz B
Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation.
Wang H; Xie H; Sun X; Kingsley PJ; Marnett LJ; Cravatt BF; Dey SK
Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):62-74. PubMed ID: 17259073
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.
Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC
Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384
[TBL] [Abstract][Full Text] [Related]
7. Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors.
Minkkilä A; Saario S; Nevalainen T
Curr Top Med Chem; 2010; 10(8):828-58. PubMed ID: 20370710
[TBL] [Abstract][Full Text] [Related]
8. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
[TBL] [Abstract][Full Text] [Related]
9. Fatty acid amide hydrolase inhibition enhances the anti-allodynic actions of endocannabinoids in a model of acute pain adapted for the mouse.
Palmer JA; Higuera ES; Chang L; Chaplan SR
Neuroscience; 2008 Jul; 154(4):1554-61. PubMed ID: 18541380
[TBL] [Abstract][Full Text] [Related]
10. Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents.
Wiley JL; Walentiny DM; Wright MJ; Beardsley PM; Burston JJ; Poklis JL; Lichtman AH; Vann RE
Eur J Pharmacol; 2014 Aug; 737():97-105. PubMed ID: 24858366
[TBL] [Abstract][Full Text] [Related]
11. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
[TBL] [Abstract][Full Text] [Related]
12. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
[TBL] [Abstract][Full Text] [Related]
13. Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain.
Valenti M; Viganò D; Casico MG; Rubino T; Steardo L; Parolaro D; Di Marzo V
Cell Mol Life Sci; 2004 Apr; 61(7-8):945-50. PubMed ID: 15095014
[TBL] [Abstract][Full Text] [Related]
14. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.
Long JZ; Nomura DK; Vann RE; Walentiny DM; Booker L; Jin X; Burston JJ; Sim-Selley LJ; Lichtman AH; Wiley JL; Cravatt BF
Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20270-5. PubMed ID: 19918051
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance.
Sugiura T; Kobayashi Y; Oka S; Waku K
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):173-92. PubMed ID: 12052034
[TBL] [Abstract][Full Text] [Related]
16. Depolarizing and calcium-mobilizing stimuli fail to enhance synthesis and release of endocannabinoids from rat brain cerebral cortex slices.
Sarmad S; Alexander SP; Barrett DA; Marsden CA; Kendall DA
J Neurochem; 2011 May; 117(4):665-77. PubMed ID: 21375532
[TBL] [Abstract][Full Text] [Related]
17. Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social behavior and emotionality at different developmental ages in rats.
Manduca A; Morena M; Campolongo P; Servadio M; Palmery M; Trabace L; Hill MN; Vanderschuren LJ; Cuomo V; Trezza V
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1362-74. PubMed ID: 25914159
[TBL] [Abstract][Full Text] [Related]
18. The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide.
Di Marzo V; Bisogno T; Sugiura T; Melck D; De Petrocellis L
Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):15-9. PubMed ID: 9512456
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Endocannabinoid-Metabolizing Enzymes in Peripheral Tissues Following Developmental Chlorpyrifos Exposure in Rats.
Buntyn RW; Alugubelly N; Hybart RL; Mohammed AN; Nail CA; Parker GC; Ross MK; Carr RL
Int J Toxicol; 2017; 36(5):395-402. PubMed ID: 28820005
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.
Lichtman AH; Hawkins EG; Griffin G; Cravatt BF
J Pharmacol Exp Ther; 2002 Jul; 302(1):73-9. PubMed ID: 12065702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]